Literature DB >> 6944694

Treatment of adult lymphoblastic leukaemia using cyclical chemotherapy with three combinations of four drugs (COAP, POMP, TRAP schedule).

S J Proctor, R Finney, W Walker, R B Thompson.   

Abstract

Seventeen adult patients with previously untreated acute lymphoblastic leukaemia (ALL) were entered into a schedule of chemotherapy in which 3 combinations, each of 4 drugs, were administered in a predetermined cyclical rotation in combination with cranial irradiation and intrathecal injections of methotrexate. Of the 17 patients, 16 completed induction therapy and 15 (94%) entered remission. The only patient with T-ALL died before receiving any therapy. The median survival for all patients (17) was 22 months. Meningeal leukaemia did not occur during the haematological remission phase although 3 patients developed this complication following relapse. The authors conclude that the addition of cyclophosphamide and cytosine arabinoside to vincristine/prednisone provides excellent remission induction but the aggressive maintenance schedule employed has not led to significant long-term survival.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6944694      PMCID: PMC2424792          DOI: 10.1136/pgmj.57.663.19

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  13 in total

1.  Treatment of acute leukemia.

Authors:  D Pinkel
Journal:  Pediatr Clin North Am       Date:  1976-02       Impact factor: 3.278

2.  Pomp combination chemotherapy of adult acute leukemia.

Authors:  V Rodriguez; J S Hart; E J Freireich; G P Bodey; K B McCredie; J P Whitecar; C A Coltman
Journal:  Cancer       Date:  1973-07       Impact factor: 6.860

3.  Cyclophosphamide (NSC-26271), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) (COAP) combination chemotherapy for acute leukemia in adults.

Authors:  J P Whitecar; G P Bodey; E J Freireich; K B McCredie; J S Hart
Journal:  Cancer Chemother Rep       Date:  1972-08

Review 4.  Treatment of acute leukemia.

Authors:  E S Henderson
Journal:  Semin Hematol       Date:  1969-07       Impact factor: 3.851

5.  Combination chemotherapy for acute lymphoblastic leukaemia in adults.

Authors:  T A Lister; J M Whitehouse; M E Beard; R L Brearley; P F Wrigley; R T Oliver; J E Freeman; R K Woodruff; J S Malpas; A M Paxton; D Crowther
Journal:  Br Med J       Date:  1978-01-28

6.  Treatment of acute lymphoblastic leukemia in adolescents and a-dults: A retrospective study of 41 patients (1970-1973).

Authors:  R Willemze; H Hillen; C A Hartgrink-Groeneveld; C Haanen
Journal:  Blood       Date:  1975-12       Impact factor: 22.113

7.  Acute lymphoblastic leukemia in adults and children. Differences in response with similar therapeutic regimens.

Authors:  T S Gee; M Haghbin; M D Dowling; I Cunningham; M P Middleman; B D Clarkson
Journal:  Cancer       Date:  1976-03       Impact factor: 6.860

8.  Acute lymphoblastic leukaemia: cyclical chemotherapy with three combinations of four drugs (COAP-POMP-CART regimen).

Authors:  A S Spiers; P D Roberts; G W Marsh; S J Parekh; A J Franklin; D A Galton; Z L Szur; E A Paul; P Husband; E Wiltshaw
Journal:  Br Med J       Date:  1975-12-13

9.  Treatment of acute leukemia in adults.

Authors:  B D Clarkson; M D Dowling; T S Gee; I B Cunningham; J H Burchenal
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

10.  Early central nervous system involvement in adults with acute non-myelogenous leukaemia.

Authors:  T A Lister; J M Whitehouse; M E Beard; A Paxton; R L Brearley; L Brown; P F Wrigley; D Crowther
Journal:  Br J Cancer       Date:  1977-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.